TPO and autoimmune thrombocytopenic purpura: In summary, for pregnant women with recurrent and refractory ITP who are unresponsive to corticosteroids and IVIG, the off-label use of TPO-RA treatment before delivery seems to be safe and effective for both mothers and the newborns.